Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry

被引：0

作者：

Casanova, M. J. ^{[1
,2
]}

Chaparro, M. ^{[1
,2
]}

Minguez, M. ^{[3
]}

Ricart, E. ^{[4
,5
]}

Taxonera, C. ^{[6
]}

Garcia-Lopez, S. ^{[7
,8
]}

Guardiola, J. ^{[9
]}

Lopez-San Roman, A. ^{[10
]}

Iglesias, E. ^{[11
]}

Beltran, B. ^{[12
,13
]}

Sicilia, B. ^{[14
]}

Vera, M. I. ^{[15
]}

Hinojosa, J. ^{[16
]}

Riestra, S. ^{[17
]}

Domenech, E. ^{[18
,19
]}

Calvet, X. ^{[20
,21
]}

Perez-Calle, J. L. ^{[22
]}

Martin-Arranz, M. D. ^{[23
,24
]}

Aldeguer, X. ^{[25
]}

Rivero, M. ^{[26
,27
]}

Monfort, D. ^{[28
]}

Barrio, J. ^{[29
]}

Esteve, M. ^{[30
]}

Marquez, L. ^{[31
]}

Lorente, R. ^{[32
,33
]}

Garcia-Planella, E. ^{[34
]}

de Castro, L. ^{[35
]}

Bermejo, F. ^{[36
,37
]}

Merino, O. ^{[38
]}

Rodriguez-Perez, A. ^{[39
]}

Martinez-Montiel, P. ^{[40
]}

Van Domselaar, M. ^{[41
]}

Alcain, G. ^{[42
]}

Dominguez-Cajal, M. ^{[43
]}

Munoz, C. ^{[44
]}

Gomollon, F. ^{[45
]}

Fernandez-Salazar, L. ^{[46
]}

Garcia-Sepulcre, M. F. ^{[47
]}

Rodriguez-Lago, I. ^{[48
]}

Gutierrez, A. ^{[49
,50
]}

Arguelles-Arias, F. ^{[51
]}

Rodriguez, C. ^{[52
]}

Rodriguez, G. E. ^{[53
]}

Bujanda, L. ^{[54
,55
]}

Llao, J. ^{[56
]}

Varela, P. ^{[57
]}

Ramos, L. ^{[58
]}

Huguet, J. M. ^{[59
]}

Almela, P. ^{[60
]}

Romero, P. ^{[61
]}

机构：

[1] Univ Autonoma Madrid, Hosp Univ Princesa, IIS IP, Madrid, Spain

[2] CIBEREHD, Gastroenterol Unit, Madrid, Spain

[3] Hosp Clin Univ Valencia, Gastroenterol Unit, Valencia, Spain

[4] Hosp Clin Barcelona, CIBEREHD, Barcelona, Spain

[5] IDIBAPS, Gastroenterol Unit, Barcelona, Spain

[6] Hosp Univ Clin San Carlos, Gastroenterol Unit, Madrid, Spain

[7] Hosp Univ Miguel Servet, Zaragoza, Spain

[8] CIBEREHD, Gastroenterol Unit, Zaragoza, Spain

[9] Hosp Univ Bellvitge, Gastroenterol Unit, Barcelona, Spain

[10] Hosp Univ Ramon y Cajal, Gastroenterol Unit, Madrid, Spain

[11] Hosp Univ Reina Sofia, Gastroenterol Unit, Cordoba, Spain

[12] Hosp Univ & Politecn La Fe, Valencia, Spain

[13] CIBEREHD, Gastroenterol Unit, Valencia, Spain

[14] Hosp Univ Burgos, Gastroenterol Unit, Burgos, Spain

[15] Hosp Univ Puerta Hierro Majadahonda, Gastroenterol Unit, Madrid, Spain

[16] Hosp Manises, Gastroenterol Unit, Valencia, Spain

[17] Hosp Univ Cent Asturias, Gastroenterol Unit, Oviedo, Spain

[18] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[19] CIBEREHD, Gastroenterol Unit, Badalona, Spain

[20] Corporacio Sanitaria Univ Parc Tauli, Hosp Sabadell, Sabadell, Spain

[21] CIBEREHD, Gastroenterol Unit, Sabadell, Spain

[22] Hosp Univ Fdn Alcorcon, Gastroenterol Unit, Madrid, Spain

[23] Hosp Univ La Paz, Madrid, Spain

[24] Inst Invest La Paz IdiPaz, Gastroenterol Unit, Madrid, Spain

[25] Hosp Univ Girona Dr Josep Trueta, Gastroenterol Unit, Girona, Spain

[26] Hosp Univ Marques Valdecilla, Santander, Spain

[27] IDIVAL, Gastroenterol, Santander, Spain

[28] Consorci Sanitari Terrassa, Gastroenterol, Tarrasa, Spain

[29] Hosp Univ Rio Hortega, Gastroenterol, Valladolid, Spain

[30] Hosp Univ Mutua Terrasa, Gastroenterol Unit, Tarrasa, Spain

[31] Hosp del Mar, Gastroenterol Unit, Barcelona, Spain

[32] Hosp Gen Univ Ciudad Real, Ciudad Real, Spain

[33] CIBEREHD, Gastroenterol Unit, Ciudad Real, Spain

[34] Hosp Santa Creu & Sant Pau, Gastroenterol Unit, Barcelona, Spain

[35] Complejo Hosp Univ Vigo, Gastroenterol Unit, Vigo, Spain

[36] Hosp Univ Fuenlabrada, Madrid, Spain

[37] Inst Invest La Paz IdiPaz, Gastroenterol Unit, Madrid, Spain

[38] Hosp Univ Cruces, Baracaldo, Spain

[39] Hosp Clin Univ Salamanca, Gastroenterol Unit, Salamanca, Spain

[40] Hosp Univ Doce Octubre, Gastroenterol Unit, Madrid, Spain

[41] Hosp Torrejon, Gastroenterol Unit, Madrid, Spain

[42] Hosp Univ Virgen Victoria, Gastroenterol Unit, Malaga, Spain

[43] Hosp Gen San Jorge, Gastroenterol Unit, Huesca, Spain

[44] Hosp Basurto, Gastroenterol Unit, Bilbao, Spain

[45] Hosp Clin Univ Lozano Blesa, Gastroentero Unit, Zaragoza, Spain

[46] Hosp Clin Univ Valladolid, Gastroenterol Unit, Valladolid, Spain

[47] Hosp Gen Univ Elche, Gastroenterol Unit, Elche, Spain

[48] Hosp Galdakao Usansolo, Gastroenterol Unit, Galdakao, Spain

[49] Hosp Gen Univ Alicante, Alicante, Spain

[50] CIBEREHD, Gastroenterol Unit, Alicante, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷

关键词：

D O I：

10.1093/ecco-jcc/jjy222.563

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P439

引用

页码：S329 / S330

页数：3

共 50 条

[1] Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry
Jose Casanova, Maria
Chaparro, Maria
Minguez, Miguel
Ricart, Elena
Taxonera, Carlos
Garcia-Lopez, Santiago
Guardiola, Jordi
Lopez-San Roman, Antonio
Iglesias, Eva
Beltran, Belen
Sicilia, Beatriz
Isabel Vera, Maria
Hinojosa, Joaquin
Riestra, Sabino
Domenech, Eugeni
Calvet, Xavier
Lazaro Perez-Calle, Jose
Dolores Martin-Arranz, Maria
Aldeguer, Xavier
Rivero, Montserrat
Monfort, David
Barrio, Jesus
Esteve, Maria
Marquez, Lucia
Lorente, Rufo
Garcia-Planella, Esther
de Castro, Luisa
Bermejo, Fernando
Merino, Olga
Rodriguez-Perez, Antonio
Martinez-Montiel, Pilar
Van Domselaar, Manuel
Alcain, Guillermo
Dominguez-Cajal, Manuel
Munoz, Carmen
Gomollon, Fernando
Fernandez-Salazar, Luis
Fe Garcia-Sepulcre, Mariana
Rodriguez-Lago, Iago
Gutierrez, Ana
Arguelles-Arias, Federico
Rodriguez, Cristina
Esther Rodriguez, Gloria
Bujanda, Luis
Llao, Jordina
Varela, Pilar
Ramos, Laura
Maria Huguet, Jose
Almela, Pedro
Romero, Patricia
INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : 606 - 616
[2] Use of mycophenolate mofetil in inflammatory bowel disease: results from the ENEIDA registry
Hernandez Camba, A.
Arranz, L.
Vera, I.
Carpio, D.
Calafat Sard, M.
Lucendo, A.
Taxonera, C.
Marin, S.
Garcia, M. J.
Suris Marin, G.
Sanchez Rodriguez, E.
Carbajo, A. Y.
De Castro, M. L.
Iborra, M.
Martin-Cardona, A.
Rodriguez Lago, I.
Busquets, D.
Bertoletti, F.
Sierra Ausin, M.
Tardillo, C.
Huguet Malaves, J.
Bujanda, L.
Castano, A.
Merino, O.
Domench, E.
Ramos, L.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S489 - S490
[3] USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM ENEIDA REGISTRY
Camba, Alejandro Hernandez
Hernandez, Laura Arranz
Vera, Isabel
Carpio, Daniel
Calafat, Margalida
Lucendo, Alfredo
Samso, Carlos Taxonera
Pedrosa, Sandra Marin
Garcia, Maria Jose
Suris, Gerard
Rodriguez, Eugenia Sanchez
Lopez, Ana Y. Carbajo
De Castro, Luisa
Iborra, Marisa
Cardona, Albert Martin
Rodriguez-Lago, Iago
Busquets, David
Bertoletti, Federico
Sierra-Ausin, Monica
Tardillo, Carlos
Huguet, Jose Maria
Bujanda, Luis
Castano, Andres
Ochoa, Olga Merino
Domenech, Eugeni
Ramos, Laura
GASTROENTEROLOGY, 2020, 158 (06) : S1213 - S1213
[4] Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Chaparro, Maria
Garre, Ana
Ricart, Elena
Iborra, Marisa
Mesonero, Francisco
Vera, Isabel
Riestra, Sabino
Garcia-Sanchez, Valle
Luisa De Castro, M.
Martin-Cardona, Albert
Aldeguer, Xavier
Minguez, Miguel
Barreiro de-Acosta, Manuel
Rivero, Montserrat
Munoz, Fernando
Andreu, Montserrat
Bargallo, Ana
Gonzalez-Munoza, Carlos
Perez Calle, Jose L.
Fe Garcia-Sepulcre, Mariana
Bermejo, Fernando
Maria Huguet, Jose
Cabriada, Jose L.
Gutierrez, Ana
Manosa, Miriam
Villoria, Albert
Carbajo, Ana Y.
Lorente, Rufo
Garcia-Lopez, Santiago
Piqueras, Marta
Hinojosa, Esther
Arajol, Claudia
Sicilia, Beatriz
Macho Conesa, Ana
Sainz, Empar
Almela, Pedro
Llao, Jordina
Roncero, Oscar
Camo, Patricia
Taxonera, Carlos
Van Domselaar, Manuel
Pajares, Ramon
Legido, Jesus
Madrigal, Rosa
Lucendo, Alfredo J.
Alcain, Guillermo
Domenech, Eugeni
Gisbert, Javier P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 839 - 851
[5] Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry
Mesonero, Francisco
Castro-Poceiro, Jesus
Benitez, Jose M.
Camps, Blau
Iborra, Marisa
Lopez-Garcia, Alicia
Torres, Paola
Esteve, Maria
Tosca, Joan
Bertoletti, Federico
Almela, Pedro
Calvet, Xavier
Vera, Isabel
Bujanda, Luis
Gomollon, Fernando
Rodriguez, Cristina
Antolin, Beatriz
Busquets, David
Hernandez, Alejandro
Rivero, Montserrat
Miquel, David Monfort i
Castano-Garcia, Andres
Gisbert, Javier P.
Domenech, Eugeni
Lopez-Sanroman, Antonio
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1021 - 1029
[6] Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
Gisbert, Javier P.
Chaparro, Maria
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
[7] Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Lobaton, T.
Ferrante, M.
Rutgeerts, P.
Ballet, V.
Van Assche, G.
Vermeire, S.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 441 - 451
[8] Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
Ortega, Triana Lobaton
Vermeire, Severine
Ballet, Vera
Rutgeerts, Paul J.
Van Assche, Gert A.
Ferrante, Marc
GASTROENTEROLOGY, 2014, 146 (05) : S579 - S579
[9] Safety of anti-TNF biologics in paediatric inflammatory bowel disease
Ruemmele, Frank M.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 813 - 815
[10] Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry
Chaparro, M.
Garre, A.
Alfaro, I.
Iborra, M.
Mesonero, P.
Vera Mendoza, I.
Rodriguez, A.
Miquel-Cusachs, J.
Riestra, S.
Navarro, P.
De Castro Parga, L.
Gonzalez-Munoza, C.
Rivero Tirado, M.
Manosa, M.
Fernandez Salazar, L.
Garcia-Sepulcre, M.
Guardiola, J.
Cabriada, J.
Gutierrez Casbas, A.
Sicilia, B.
Perez Calle, J. L.
Piqueras, M.
Guerra, I.
Roncero, O.
Navarro-Llavat, M.
Sainz, E.
Barrio, J.
Calvet, X.
Garcia, A.
Llorente Barrio, M.
Lorente, R.
Almela, P.
Madrigal, R.
Lucendo Villarin, A. J.
Pajares, R.
Van Domselaar, M.
Legido Gil, J.
Gisbert, J. P.
JOURNAL OF CROHNS & COLITIS, 2018, 12 : S447 - S448

← 1 2 3 4 5 →